期刊文献+

垂体形态正常的特发性生长激素缺乏症在MR动态增强扫描中的特征 被引量:4

Assessment of idiopathic growth hormone deficiency in the morphologically normal pituitary using dynamic contrast-enhanced MR imaging
下载PDF
导出
摘要 目的评估MR动态增强扫描在垂体形态正常的特发性生长激素缺乏症(IGHD)中的应用价值。材料与方法选择21例垂体形态正常的IGHD患者及17名正常人,两组均接受垂体冠状面多层面MR动态增强扫描。测量垂体前叶信号强度-时间(SI-T)曲线,记录强化峰值时间(TTP)及最大强化率(Rmax),使用独立样本t检验对比分析两组TTP及Rmax的差异性。对IGHD组TTP、Rmax与生长激素水平进行皮尔森相关系数分析。结果 IGHD患者TTP比正常对照组延长(P<0.05),两组间Rmax差异无统计学意义(P>0.05)。生长激素水平与TTP存在负相关(P<0.05),与Rmax无明显相关性(P>0.05)。结论 MR动态增强扫描中TTP的延长对有临床症状且垂体形态正常的IGHD患者有提示及辅助诊断作用。生长激素水平的缺乏与垂体前叶局部灌注延迟存在关联性。 Objectives: To investigate the dynamic contrast-enhanced MR imaging features of pituitary in the idiopathic growth hormone deficiency(IGHD) patients with morphologically normal pituitary gland.Materials and Methods: 21 IGHD patients with normal pituitary morphology and 17 healthy age-matched controls were included for analysis.Multisection coronal dynamic contrast-enhanced MR imaging of pituitary was performed.Time to peek(TTP) and maximum enhancement ratio(Rmax) were derived from the signal intensity-time curve of anterior pituitary and compared between IGHD patients and normal controls using the independent t test.Pearson correlation analysis was used to determine the correlation between the TTP or Rmax and the growth hormone deficiency levels.Results: The IGHD patients had a prolonged TTP than normal controls(P0.05),but the Rmax was not significantly different from that in normal controls(P0.05).The levels of serum growth hormone were negatively correlated with the TTP(P0.05),but not with Rmax(P0.05).Conclusions: A delayed TTP on dynamic contrast-enhanced MR imaging could be indicative of IGHD in symptomatic patients with a morphologically normal pituitary.The degree of growth hormone deficiency was associated with regional perfusion delay.
出处 《磁共振成像》 CAS CSCD 2013年第4期252-256,共5页 Chinese Journal of Magnetic Resonance Imaging
关键词 侏儒症 垂体性 垂体 前叶 磁共振成像 Dwarfism pituitary Pituitary gland anterior Magnetic resonance imaging
  • 相关文献

参考文献14

  • 1Audi L, Fernandez-Cancio M, Camats N, et al. Growth hormone deficiency: an update. Minerva Endocrinol, 2013, 38(1): 1-16.
  • 2Kalina MA, Kalina-Faska B, Gruszczyflska K, et al. Usefulness of magnetic resonance findings of the hypothalamic-pituitary region in the management of short children with growth hormone deficiency: evidence from a longitudinal study. Childs Nerv Syst, 2012, 28(1): 121-127.
  • 3Bozzola M, Adamsbaum C, Biscaldi I, et al. Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency. Clin Endocrinol (Oxf), 1996, 45(1 ): 21-26.
  • 4Maghnie M, Genovese E, Arico M, et al. Evolving pituitary hormone deficiency is associated with pituitary vasculopathy: dynamic MR study in children with hypopituitarism, diabetes insipidus, and Langerhans cell histiocytosis. Radiology, 1994, 193(2): 493-499.
  • 5Genovese E, Maghnie M, Beluffi G, et ah Hypothalamic-pituitary vascularization in pituitary stalk transection syndrome: is the pituitary stalk really transected? The role of gadolinium-DTPA with spin-echo T 1 imaging and turbo-FLASH technique. Pediatr Radiol, 1997, 27(1): 48-53.
  • 6Galluzzi F, Quaranta MR, Salti R, et al. Diagnosis of growth hormone deficiency by using the arginine provocative test: is it possible to shorten testing time without altering validity. Horm Res, 2009, 72(3): 142-145.
  • 7Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. AJNR Am J Neuroradiol, 1997, 18(3): 551-554.
  • 8lkram MF, Sajjad Z, Shokh I, et al. Pituitary height on magnetic resonance imaging observation of age and sex related changes. J Pak Med Assoc, 2008, 58(5): 261-265.
  • 9Shigematsu Y, Korogi Y, Kitajima M, et al. Abnormal perfusion of the pituitary gland secondary to dural arteriovenous fistulas in the cavernous sinus: dynamic MR findings. AJNR Am J Neuroradiol, 2003, 24(5): 930-936.
  • 10Maier C, Riedl M, Clodi M, et al. Dynamic contrast-enhanced MR imaging of the stimulated pituitary gland. Neuroimage, 2004, 22(1): 347-352.

同被引文献50

  • 1林光武,张涛,杨宁,蔡丰,史轶蘩,邓洁英,张逻东,姜亚云.正常青少年垂体MRI研究[J].中华放射学杂志,2005,39(10):1022-1027. 被引量:39
  • 2刘影,李传福,张杨,孟祥水,侯金文,张凯,郑金勇,丛培新.垂体柄阻断综合征的MRI诊断[J].中华放射学杂志,2006,40(3):324-325. 被引量:40
  • 3田静,王光彬,李桂梅,谢蓉蓉.垂体柄阻断综合征的MRI诊断[J].实用放射学杂志,2007,23(9):1153-1154. 被引量:9
  • 4Ioachi mescu AG,Hamrahian AH,Stevens M,et al.The pituitary stalk transection syndro me:multifaceted presentation in adulthood.Pituitary,2012,15(3):405-411.
  • 5Guo Q,Yang Y,Mu Y,et al.Pituitary stalk interruption syndrome in chinese people:clinical characteristic analysis of 55 cases.PLoS ONE,2013,8(1):53-57.
  • 6Ouyang T,Rothfus WE,Ng JM,et al.Imaging of the pituitary.Radiol Clin,2011,49(3):549-571.
  • 7Older CA,Elster AD.Magnetization transfer imaging of the pituitary:further insights into the nature of posterior“bright spot”.J Comput Assist Tomogr,1997,21(7):171-176.
  • 8Pinto G,Netchine I,Sobrier ML,et al.Pituitary stalk interruption syndrome:a clinical-biological-genetic assessment of its pathogenesis.Clin Endocrinol Metab,1997,82(10):3450-3454.
  • 9Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol, 2006, 24(20): 3293-3298.
  • 10Bernstein JM, Homer J J, West CM. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review. Oral Oncol, 2014, 50(10): 963-970.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部